Valuation: Quest Laboratories Limited

Market Cap 171.08Cr 1.79Cr 1.53Cr 1.43Cr 1.31Cr 2.46Cr 2.49Cr 17Cr 6.6Cr 86Cr 6.71Cr 6.57Cr 284.26Cr P/E 2024 *
-
P/E 2025 12.4x
Enterprise Value 152Cr 1.59Cr 1.36Cr 1.27Cr 1.17Cr 2.19Cr 2.22Cr 15Cr 5.87Cr 76Cr 5.97Cr 5.84Cr 252.56Cr EV / Sales 2024 *
-
EV / Sales 2025 1.43x
Free-Float
99%
Yield 2024 *
-
Yield 2025 -
1 day-1.21%
1 week-6.12%
Current month-3.81%
1 month-7.64%
3 months-20.51%
6 months-30.03%
Current year-22.03%
1 week 85.15
Extreme 85.15
93
1 month 85.15
Extreme 85.15
96.75
Current year 85.15
Extreme 85.15
152.6
1 year 84
Extreme 84
152.6
3 years 75.15
Extreme 75.15
196.8
5 years 75.15
Extreme 75.15
196.8
10 years 75.15
Extreme 75.15
196.8
Manager TitleAgeSince
Chief Executive Officer 59 01/01/2024
Director of Finance/CFO 38 01/01/2024
Compliance Officer - 03/09/2025
Director TitleAgeSince
Chairman 59 01/01/2024
Director/Board Member 31 05/03/2021
Director/Board Member 72 10/01/2024
Change 5-day change 1-year change 3-year change Capi.($)
-1.21%-6.12%-13.93% - 1.47Cr
+0.88%+6.38%+76.40%+126.75% 1,11900Cr
+1.07%+3.80%+50.73%+62.78% 65TCr
+1.20%+6.21%+25.81%+78.74% 47TCr
+1.02%+5.77%+43.63%+48.43% 37TCr
+0.85%+4.07%+24.97%+40.58% 30TCr
+1.26%+6.81%+2.27%+14.41% 26TCr
+1.88%+5.81%+49.57%+70.53% 24TCr
+1.59%+2.09%-17.33%-52.62% 21TCr
+1.87%+5.61%+27.32%+91.38% 18TCr
Average +1.04%+3.86%+26.94%+53.44% 38TCr
Weighted average by Cap. +1.14%+5.09%+44.26%+72.65%

Financials

2024 2025
Net sales 83Cr 86.29L 73.92L 69.16L 63.31L 1.19Cr 1.2Cr 8.17Cr 3.19Cr 41Cr 3.24Cr 3.17Cr 137.18Cr 103.97Cr 1.09Cr 93.08L 87.09L 79.72L 1.5Cr 1.52Cr 10Cr 4.01Cr 52Cr 4.08Cr 3.99Cr 172.74Cr
Net income 10Cr 10.55L 9L 8L 8L 14.53L 14.72L 99.9L 38.96L 5.07Cr 39.61L 38.75L 17Cr 14Cr 14.18L 12.15L 11.36L 10.4L 19.52L 19.78L 1.34Cr 52.36L 6.82Cr 53.24L 52.08L 23Cr
Net Debt 4.94Cr 5L 4L 4L 4L 7L 7L 48.87L 19.06L 2.48Cr 19.38L 18.95L 8.2Cr -19Cr -19.94L -17.08L -15.98L -14.63L -27.46L -27.82L -1.89Cr -73.64L -9.58Cr -74.88L -73.25L -32Cr
Logo Quest Laboratories Limited
Quest Laboratories Limited is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC). These products are available in various forms, such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. The tablets include Cetirizine Hydrochloride Tablet IP 10 mg, Zinc Sulphate Dispersible Tablet IP, Diclofenac Sodium Tablet BP, and others. It offers dry syrup and suspension, such as Ferrous Sulphate & Folic Acid Syrup, Albendazole Suspension IP, Zinc Oral Solution USP, Alpha Amilase & Pepsine, Sucralfate Suspension, and others. Its ointments include Silver Sulphadiazine Cream IP, Diclofenac Diethylamino IP Gel, and Povidone Iodine Ointment USP.
Employees
-
Date Price Change Volume
21/26/21 ₹85.85 -1.21% 13,200
20/26/20 ₹86.90 -2.36% 6,000
19/26/19 ₹89.00 +1.08% 4,800
18/26/18 ₹88.05 0.00% 7,200
17/26/17 ₹88.05 -3.72% 33,600
  1. Stock Market
  2. Stocks
  3. QUESTLAB Stock